C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
11/2007
11/15/2007	WO2007108011A3 Process for the preparation of highly pure donepezil
11/15/2007	WO2007094858A3 Process for amination of acrylic macromonomers and products therefrom
11/15/2007	WO2007056469A3 Certain chemical entities, compositions, and methods
11/15/2007	US20070265450 Novel processes for the preparation of (r)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
11/15/2007	US20070265449 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
11/15/2007	US20070265348 Therapeutic guanidines
11/15/2007	US20070265315 An urea compounds containing a pyridine, quinoline, or isoquinoline functionality; p38 mediated diseases such as inflammation and VEGF mediated diseases such as angogenesis disorders
11/15/2007	US20070265310 Biphenyl compounds useful as muscarinic receptor antagonists
11/15/2007	US20070265306 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
11/15/2007	US20070265305 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; biphenyl carbamate derivative
11/15/2007	US20070265302 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
11/15/2007	US20070265296 Nuclear receptor binding agents
11/15/2007	US20070265279 Use of mGluR5 antagonists for the treatment of pruritic conditions
11/15/2007	US20070265261 Dpp-IV Inhibitors
11/15/2007	US20070265254 Naphthaline derivatives as H3 inverse agonists
11/15/2007	US20070265248 Substituted piperazines and methods of use
11/15/2007	US20070265165 Novel herbicides
11/14/2007	EP1854785A1 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
11/14/2007	EP1853583A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/14/2007	EP1853562A1 Lercanidipine free base
11/14/2007	EP1853561A1 PROCESS FOR PRODUCING POLYMORPH FORM (I) OF l-BENZYL-4- [(5, 6-DIMETHOXY-l-INDANONE) -2YL]METHYL PIPERIDINE HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)
11/14/2007	EP1853560A1 Dopamine transporter inhibitors for use in treatment of movement disorders and other cns indications
11/14/2007	EP1853556A1 Derivatives of aminobutanoic acid inhibiting cpt
11/14/2007	EP1853553A1 Substituted hydroxyethylamines
11/14/2007	EP1853550A1 Indane
11/14/2007	CN101072561A Diaminoalkane aspartic protease inhibitors
11/14/2007	CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/14/2007	CN101070303A Method for preparing methylamino hexahydropyridine
11/13/2007	US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007	US7294639 E.g., 3-(3'-{[(1-biphenyl-4-ylmethanoyl)methyl-amino]methyl}biphenyl-4-yl)-2-ethoxypropionic acid and 2-ethoxy-3-(3'-{[methyl-(6-oxo-6-phenylhexanoyl)amino]methyl}biphenyl-4-yl)propionic acid; regulating and/or restoring skin lipid metabolism; treating a wide variety of skin disorders
11/13/2007	US7294637 Such as [1-(4-chloro-phenyl)-cyclobutyl]-(3-hydroxymethyl piperidin-1-yl)-methadone for treating cocaine and/or methamphetamine addiction
11/13/2007	US7294636 Chemical compounds
11/13/2007	US7294630 Piperazinyl piperidine tachykinin antagonists
11/13/2007	CA2352544C Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
11/13/2007	CA2289013C Chemical process for the reduction of 1-substituted-3-hydroxymethyl-4-(4-fluorophenyl)tetrahydropyridines
11/13/2007	CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/13/2007	CA2209904C Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity
11/08/2007	WO2007127297A2 Crystalline forms of a dimethylphenyl compound
11/08/2007	WO2007127196A2 DIALKYLPHENYL COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
11/08/2007	WO2007126988A2 Selective androgen receptor modulators and methods of use thereof
11/08/2007	WO2007126362A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
11/08/2007	WO2007125952A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007	WO2007125364A1 Piperidines and related compounds for treatment of alzheimer’s disease
11/08/2007	WO2007107352A8 Agents that disrupt cellular replication and their use in inhibiting pathological conditions
11/08/2007	WO2007084450A3 Cannibinoid receptor modulators
11/08/2007	WO2007062334A3 New pleuromutilin derivative and its use
11/08/2007	WO2007062333A3 New pleuromutilin derivative and its use
11/08/2007	US20070260064 dosage forms of pimavanserin tartrate, serotonin receptor antagonists, used for the treatment of psychological disorders
11/08/2007	US20070259922 Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/08/2007	US20070259918 2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor
11/08/2007	US20070259917 Processes for the synthesis of 3-isobutylglutaric acid
11/08/2007	US20070259914 Novel Piperidine Derivates as Modulators of Chemokine Receptor Ccr5.
11/08/2007	US20070259898 NOVEL 2-AMINO-3,4-DIHYDRO-PYRIDO[3,4-D]PYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF beta-SECRETASE (BACE)
11/08/2007	US20070259863 Arylphenylamino-,Arylphenylamide-, and Arylphenylether-Sulfide Derivatives
11/08/2007	US20070259852 Such as 2-(2-hydroxycarbamoylmethyl-3-oxo-2,3-dihydro-benzo[1,4]thiazin-4-yl)-propionamide; peptidyl deformylase (PDF) inhibitors; for treatment of bacterial infections
11/08/2007	US20070258905 Contrast Agents Endowed with High Relaxivity for Use in Magnetic Resonance Imaging (Mri) Which Contain a Chelating Moiety with Polyhydroxylated Substituents
11/08/2007	DE60021370C5 Piperazinderivate verwendbar als ccr5 antagonisten Piperazine derivatives useful as antagonists ccr5
11/08/2007	CA2650914A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's disease and/or schizophrenia
11/08/2007	CA2650683A1 Amine derivative having npy y5 receptor antagonist activity
11/08/2007	CA2650631A1 Crystalline forms of a dimethylphenyl compound
11/08/2007	CA2650530A1 Dialkylphenyl compounds having .beta.2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/08/2007	CA2649996A1 Piperidines and related compounds for treatment of alzheimer's disease
11/08/2007	CA2648884A1 Abnormal cannabidiols as agents for lowering intraocular pressure
11/08/2007	CA2646474A1 Processes for the synthesis of 3-isobutylglutaric acid
11/07/2007	EP1852422A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses
11/07/2007	EP1851201A1 1-{4-[(1-cyclobutyl-4-piperidinyl)oxy]phenyl}-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine as histamine h3 antagonist
11/07/2007	CN101068916A Use of atazanavir for improving the pharmacokinetics of drugs metabolized by UGT1A1
11/07/2007	CN101068782A Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines
11/07/2007	CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007	CN101068551A 喹啉速激肽受体拮抗剂 Quinoline tachykinin receptor antagonists
11/07/2007	CN100347168C Indazolamides with analgesic activity
11/07/2007	CN100347151C Novel aminobenzoephenones
11/06/2007	USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007	US7291632 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists
11/06/2007	US7291617 Arylamidine derivative or salt thereof
11/06/2007	CA2263927C Heterocyclic thioesters and ketones
11/06/2007	CA2228511C New process for preparing norbenzomorphan, an intermediate in the preparation of pharmaceutically useful benzomorphan derivatives, particularly (-)-(1r,5s,2"r)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphan
11/06/2007	CA2223112C 1,2-bis-adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/01/2007	WO2007124424A2 Il-8 receptor antagonists
11/01/2007	WO2007123718A1 1-HETEROCYCLYLAMINO-2-HYDROXY-3-AMINO-ω-ARYLALKANES
11/01/2007	WO2007123465A1 New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder
11/01/2007	WO2007123405A1 Ropivacaine hydrochloride anhydrate and the preparation thereof
11/01/2007	WO2007087135A3 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
11/01/2007	WO2007057768A3 Sulfonyl derivatives
11/01/2007	WO2007054969A3 Process for the preparation of lercanidipine and amorphous form of lercanidipine hydrochloride
11/01/2007	WO2007047146A3 Inhibitors of viral replication
11/01/2007	WO2006097460A8 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
11/01/2007	US20070255062 Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators
11/01/2007	US20070254926 Pyridylphenyl compounds for inflammation and immune-related uses
11/01/2007	US20070254919 Aroyl-O-Piperidine Derivatives for the Treatment of Diabetes-Related Problems
11/01/2007	US20070254918 Dopamine-, Norepinephrine- and Serotonin- Transporter-Selective Heterocyclic Compounds and Their Therapeutic Applications
11/01/2007	US20070254881 Pyrazole Derivative
11/01/2007	US20070254880 Heteroaryl Piperidine Glycine Transporter Inhibitors
11/01/2007	US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007	US20070254874 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/01/2007	CA2650009A1 Il-8 receptor antagonists
10/2007
10/31/2007	EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007	EP1848275A1 Kappa opioid receptor ligands
10/31/2007	EP1687638B1 Analysis of mass spectral data in the quiet zones
10/31/2007	EP1567495A4 Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors

1 ... 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 ... 380